Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867346 · ClinicalTrials.gov registry record

Early Markers of Cognitive Change and Alzheimer s Disease

A clinical trial, sponsored by National Institute on Aging (NIA).

Completed
Registry status
2,850
Enrollment target

NCT01867346: Completed study, sponsored by National Institute on Aging (NIA).

NCT01867346 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 2,850 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867346 has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
2,850 participants
Enrollment target

Study Summary

Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a long-term study of human aging. To see how the brain changes with age, researchers will study BLSA participants who are at least 60 years old. In particular, researchers are looking for early markers of possible Alzheimer's disease and other conditions that cause memory loss. To do so, they will give tests of memory and brain function, and stay in close contact with participants. Objectives: \- To study cognitive changes that occur in normal aging and in people who develop memory problems. Eligibility: \- Individuals at least 60 years of age who are participating in the BLSA. Design: * There are three parts to this study. These study procedures will be done under the usual BLSA guidelines. * Participants will take paper and pencil tests. The tests measure skills such as language, attention, memory, and problem solving. They will also ask questions about emotions and feelings. * Participants will give the name and phone number of a person who knows them well and sees them often. Researchers will ask this person to fill out questionnaires on the effects of aging on the participant. These questions will monitor the participant's memory and ability to function independently. * Participants will have regular phone calls between study visits. These calls will help to keep their information up to date. * Participants will continue on this study for as long as they are able to participate.

Trial Details

FieldValue
Enrollment Target 2,850 participants
Start Date 2003-03-19
Est. Completion 2015-01-02
National Institute on Aging (NIA)

131 total trials

What the finished NCT01867346 record still lists

NCT01867346 is an observational study that tracks outcomes without assigning an intervention. Its 2,850 participants enrollment target places it among the larger protocols in the corpus.

The record links to 0 conditions, and to 0 interventions.

NCT01867346 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01867346 about?

NCT01867346 is a clinical study titled "Early Markers of Cognitive Change and Alzheimer s Disease". Background: \- The Baltimore Longitudinal Study of Aging (BLSA) is a long-term study of human aging. To see how the brain changes with age, researchers will study BLSA participants who are at least 60 years old. In particular, researchers are looking for early markers of possible Alzheimer's diseas...

What is the current status of trial NCT01867346?

This trial is currently completed. The enrollment target is 2,850 participants. The study started on 2003-03-19. Estimated completion is 2015-01-02.

Who is sponsoring clinical trial NCT01867346?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06150781 · 2,842 participants

    Aimovig Pregnancy Exposure Registry

  • NCT06351085 · 2,869 participants · NA

    Enhancing Lung Cancer Screening Through Human-Centered Intervention

  • NCT05624450 · 2,870 participants · Phase 3

    Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

  • NCT02273297 · 2,821 participants

    Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01867346, the US trial registry maintained by the National Library of Medicine. NCT01867346 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.